ArticleStem cell research & therapy2026

Preclinical efficacy of combination therapy with allogeneic induced pluripotent stem cell-derived invariant natural killer T and α-galactosylceramide-pulsed antigen-presenting cells.

Takahiro Aoki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.